Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03573271 · ClinicalTrials.gov registry record · NA
Pivotal Study to Evaluate the Safety and Efficacy of a Micro-coring Device Treating Moderate to Severe Facial Wrinkles
A NA study, sponsored by Cytrellis Biosystems.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03573271 is a NA study that has completed, run by Cytrellis Biosystems. The registered enrollment target is 30 participants.
The verdict
NCT03573271, a NA study, has completed, sponsored by Cytrellis Biosystems.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
Study evaluating the safety and efficacy of a micro-coring device for the treatment of moderate to severe cheek wrinkles.
Interventions
- DEVICE MCD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2018-03-26 |
| Est. Completion | 2019-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03573271
The ClinicalTrials.gov registry entry for NCT03573271 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cytrellis Biosystems, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MCD is the first listed.
NCT03573271 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03573271 about?
NCT03573271 is a clinical study titled "Pivotal Study to Evaluate the Safety and Efficacy of a Micro-coring Device Treating Moderate to Severe Facial Wrinkles". Study evaluating the safety and efficacy of a micro-coring device for the treatment of moderate to severe cheek wrinkles.
What is the current status of trial NCT03573271?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2018-03-26. Estimated completion is 2019-02-28.
What interventions are being tested in trial NCT03573271?
The interventions under investigation include: MCD (DEVICE).
Who is sponsoring clinical trial NCT03573271?
This trial is sponsored by Cytrellis Biosystems, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.